FDA Rx pregnancy labeling guidance under development; public hearing planned.
Executive Summary
FDA Rx PREGNANCY LABELING TASK FORCE PREPARING GUIDANCES on "interpretation of reproductive and developmental toxicity data from animals" and on "interpretation of human exposure data," the agency said in a July 31 Federal Register notice. The agency task force "will also consider other possible actions that may be necessary to make pregnancy labeling content more consistent, informative and accessible," the notice states.
You may also be interested in...
Pregnancy Label Due Date Approaching? Risk, Clinical Info Could Be Split
FDA is seeking to move ahead quickly with new regulations for pregnancy labeling following the release of the physician labeling final rule
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011